The Role of Ontology in Big Cancer Data: Difference between revisions
From NCOR Wiki
Jump to navigationJump to search
mNo edit summary |
mNo edit summary |
||
| Line 29: | Line 29: | ||
*Charles Sawyer | *Charles Sawyer | ||
*David Hausler | *David Hausler | ||
*Yongqun He (Michigan) | |||
*Steven Channock | *Steven Channock | ||
*Lynn Schriml | *Lynn Schriml | ||
Revision as of 20:18, 10 October 2014
Date: May 12-13, 2015
Day 1 (10am-5pm) and Day 2 (9am-noon) will be a smaller meeting, up to 40 people, at NCI Shady Grove.
Day 2 Afternoon (1-3pm): public session in Natcher.
The topic is: The Role of Ontology in Big Cancer Data
Possible subtopics include:
TCGA (e.g. How to expand TCGA to give an enhanced role to proteomics) Ontology work (for example using the PRO) on actionable mutations Applications to personalized medicine IoM new disease taxonomy Big Cancer Imaging Data Clinical genomics
Sponsors: National Cancer Institute, National Center for Biomedical Ontology
